HCW Biologics Inc (HCWB : NASDAQ)
Common Stock
$1.99
USD
+0.33 (19.88%)
Last updated: 2026-09-24
Follow HCWB
HCWB
HCW Biologics Inc
WealthAwesomePerformance
1 Day
+19.88%
1 Week
+2.05%
1 Month
-23.46%
YTD
-69.85%
Key Statistics
Market Cap
$3.05M
52W High
$29.28
52W Low
$1.50
P/E Ratio
-
50 Day MA
$2.83
200 Day MA
$5.13
Beta
2.38
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/24/2026 | $1.69 | $3.12 | $1.67 | $1.99 | $1.99 | 13,562,091 |
| 9/23/2026 | $1.81 | $1.83 | $1.61 | $1.66 | $1.66 | 161,354 |
| 9/22/2026 | $1.91 | $1.98 | $1.70 | $1.81 | $1.81 | 133,709 |
| 9/21/2026 | $1.95 | $2.02 | $1.87 | $1.91 | $1.91 | 59,064 |
| 9/18/2026 | $2.00 | $2.15 | $1.87 | $1.87 | $1.87 | 87,500 |
| 9/17/2026 | $2.05 | $2.07 | $1.94 | $1.95 | $1.95 | 64,959 |
| 9/16/2026 | $2.09 | $2.10 | $1.89 | $2.01 | $2.01 | 86,445 |
| 9/15/2026 | $2.17 | $2.19 | $2.05 | $2.05 | $2.05 | 55,473 |
| 9/14/2026 | $2.24 | $2.33 | $2.18 | $2.20 | $2.20 | 100,024 |
| 9/11/2026 | $2.43 | $2.44 | $2.16 | $2.24 | $2.24 | 94,710 |
Analyst Price Targets
Based on 1 analyst covering HCWB · as of Sep 17, 2026
Wall Street analysts forecast HCWB stock price to rise 1407.5% over the next 12 months.
Consensus
Buy4.00 / 5.00
Avg. Target
US$30.00
+1407.5% Upside
Current Price
US$1.99
Last close
Analyst Breakdown (1 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on HCWB's historical volatility
30-Day Vol
136.9%
Annualized
90-Day Vol
121.3%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
US$1.66
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$1.88 | US$1.17 – US$3.01 |
| 60 trading days | US$1.77 | US$0.91 – US$3.45 |
| 90 trading days | US$1.66 | US$0.73 – US$3.77 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About HCW Biologics Inc
HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and diseases in the United States. Its lead products include HCW11-018b, a novel, tetra-valent T-Cell engager; HCW11-040, a multifunctional fusion molecule that is a combination of cytokines and pembrolizumab; and HCW9302, injectable and interleukin 2 (IL-2) fusion protein complex, which is in clinical trial in patients with alopecia areata diseases. The company also develops HCW9201, a fusion protein designed as a reagent to use in the production of natural killer (NK) cell-based therapies; HCW9206, a fusion protein designed as a reagent to use in the production of CAR-therapies for the treatment of infectious diseases; and HCW11-006, a multi-functional immune cell stimulator. It has a license agreement with Wugen Inc. to develop cell therapy-based treatments; and a license, research and co-development agreement with WY Biotech Co., Ltd. for its preclinical molecule. HCW Biologics Inc. was incorporated in 2018 and is headquartered in Miramar, Florida.
Financials
- Revenue (TTM)
- $6.72M
- EBITDA
- $-5.58M
- Profit Margin
- -83.05%
- ROE (TTM)
- -151.36%
- EPS (Diluted)
- -15.33
- Book Value
- 4.59
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About HCWB.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| RPGL | Republic Power Group Limited Class A Ordinary Shares | $14.69 | +1363.23% |
| KITT | Nauticus Robotics Inc. | $2.93 | +459.21% |
| ZWZZT | NASDAQ TEST STOCK | $24.50 | +144.51% |
| SRZN | Surrozen Inc | $33.68 | +108.42% |
| GLND | Greenland Energy Company Common Stock | $5.35 | +83.85% |
| PMAX | Powell Max Limited Class A Ordinary Shares | $1.65 | +80.62% |
| STAK | STAK Inc. Ordinary Shares | $1.44 | +53.19% |
| PFSA | Profusa, Inc. Common Stock | $3.03 | +47.80% |